GILEAD SCIENCES, INC. Stockholders' Equity 2006-2026 | GILD
What is stockholders' equity?
Stockholders' equity can be defined as total assets minus total liabilities, representing the owners' residual interest in the company after all debts are paid.
What is GILEAD SCIENCES, INC.'s current stockholders' equity?
GILEAD SCIENCES, INC. (GILD) annual stockholders' equity for 2025 was $22.62B, a 17.52% increase from 2024. GILEAD SCIENCES, INC. stockholders' equity for the quarter ending March 31, 2026 was $23.43B.
What was GILEAD SCIENCES, INC.'s stockholders' equity in 2024?
GILEAD SCIENCES, INC. annual stockholders' equity for 2024 was $19.25B, a 15.40% decline from 2023.
What was GILEAD SCIENCES, INC.'s stockholders' equity in 2023?
GILEAD SCIENCES, INC. annual stockholders' equity for 2023 was $22.75B, a 7.26% increase from 2022.
What is GILEAD SCIENCES, INC.'s 5-year stockholders' equity CAGR?
GILEAD SCIENCES, INC. stockholders' equity grew at a compound annual growth rate (CAGR) of 4.42% from FY2020 to FY2025, going from $18.22B to $22.62B over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $22.62B | +17.5% | 10-K |
| FY2024 | $19.25B | -15.4% | 10-K |
| FY2023 | $22.75B | +7.3% | 10-K |
| FY2022 | $21.21B | +0.7% | 10-K |
| FY2021 | $21.06B | +15.6% | 10-K |
| FY2020 | $18.22B | -19.6% | 10-K |
| FY2019 | $22.65B | +5.2% | 10-K |
| FY2018 | $21.53B | +5.0% | 10-K |
| FY2017 | $20.50B | +5.9% | 10-K |
| FY2016 | $19.36B | +1.3% | 10-K |
| FY2015 | $19.11B | +20.8% | 10-K |
| FY2014 | $15.82B | +34.7% | 10-K |
| FY2013 | $11.74B | +23.1% | 10-K |
| FY2012 | $9.54B | +39.0% | 10-K |
| FY2011 | $6.87B | +12.2% | 10-K |
| FY2010 | $6.12B | -5.9% | 10-K |
| FY2009 | $6.51B | +45.7% | 10-K |
| FY2008 | $4.47B | +19.0% | 10-K |
| FY2007 | $3.75B | +82.9% | 10-K |
| FY2006 | $2.05B | - | 10-K |